Back
A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO
Abstract number: P-W-459
Romay-Penabad1 Z., Urbanus2 R.T., Pennings2 M.T., Montiel-Manzano1 G., DeGroot2 P., Pierangeli1 S.S.
11Medicine-Rheumatology, University of Texas Medical Branch, Galveston, United States 22Medicine, Utrecht University, Utrecht, Netherlands
How-to-cite Romay-Penabad Z, Urbanus RT, Pennings MT, Montiel-Manzano G, DeGroot P, Pierangeli SS. A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO. J Thromb Haemost 2007; 5 Supplement 2: P-W-459
Abstract
Introduction: It has been shown that endothelial cell (EC) activation and tissue factor (TF) upregulation in EC and monocytes by anti- b2glycoprotein I (anti-b2GPI) antibodies leads to a prothrombotic state. In previous studies, dimers of b2GPI were shown to mimic the effects of b2GPI-anti- b2GPI complexes in that they increased platelet adhesion to collagen. Here we examined the effects of a dimeric form of b2GPI on thrombosis and TF activity in vivo in mice.
Methods: We treated CD1 mice with 50 mg/mL (i.p) recombinant dimeric b2GPI or with recombinant monomeric b2GPI twice at 0 and 48 hours later. The size of an induced thrombus in the femoral vein of the mice was examined as described elsewhere. TF activity was determined using a chromogenic assay in homogenates of carotid arteries, and in peritoneal cells of mice
Results: In vivo, b2GPI dimer increased significantly the size of the induced thrombi when compared to mice treated with control protein. Treatment of the mice with the b2GPI dimer also induced significantly increased TF function in peritoneal cells and in homogenates of carotid arteries (Table).
Table:
| Treatment | Thrombus size (mean SD, mm<SU | TF in carotid artery (pM/mg protein) | TF in macrophages (pM/mg protein) |
|---|
| Dimer | 51873801 | 312 | 130 |
| Control Peptide | 552 | 238 | 42 |
Conclusions: The data show that a dimeric form of b2GPI mimics the effect of anti-b2GPI antibodies in vivo and causes TF upregulation that may lead to thrombosis. Thus when b2GPI is dimerised, it can induce thrombosis in mice independently of the presence of antibodies. These findings may be important in understanding the pathogenic mechanisms of thrombosis in Antiphospholipid Syndrome (APS).
To cite this abstract use the following format:
Journal of Thrombosis and Haemostasis 2007; Volume 5, Supplement 2: abstract number
Session Details
| Date: |
01/08/2007
|
| Time: |
00:00-00:00
|
| Session name: |
XXIst ISTH Congress |
| Subject: |
|
| Location: |
Oxford, UK |
| Presentation type: |
|
| Back to top |
|